TrialBMC cancer2013

Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II study.

Marta Martín-Richard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.